Bin Lü
-
- Pituitary Gland Disorders and Treatments 12
- Diabetes, Cardiovascular Risks, and Lipoproteins 10
- Growth Hormone and Insulin-like Growth Factors 9
- Diabetic Foot Ulcer Assessment and Management 9
- Nephrology top 2%
- Hepatology top 5%
- Physiology top 5%
- Pain Mechanisms and Treatments 17
-
- Liver Disease Diagnosis and Treatment 11
-
- Cardiovascular Health and Disease Prevention 10
-
- Botulinum Toxin and Related Neurological Disorders 10
- Co-authors
- Renming HuZhaoyun ZhangJie WenYehong YangShuo ZhangHangping ZhengLinuo ZhouYiming Li
- Journals
- Diabetes Research and Clinical Practice (11 papers)Diabetology & Metabolic Syndrome (5 papers)Infection and Drug Resistance (3 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Bin Lü
150 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 156
- Endocrinology, Diabetes and Metabolism 768
- Nephrology 230
- Hepatology 184
- Physiology 571
- Endocrine and Autonomic Systems 115
Countries citing papers authored by Bin Lü
This map shows the geographic impact of Bin Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Lü more than expected).
Fields of papers citing papers by Bin Lü
This network shows the impact of papers produced by Bin Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Lü. The network helps show where Bin Lü may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bin Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 38 | |
| 9 | 2022 | 7 | |
| 10 | 2019 | 87 | |
| 11 | 2018 | 2 | |
| 12 | 2018 | 213 | |
| 13 | 2017 | 23 | |
| 14 | The estimated glomerular filtration rate is associated with subclinical atherosclerosis, independently of albuminuria, in patients with type 2 diabetes. | 2013 | 7 |
| 15 | 2012 | 47 | |
| 16 | 2012 | 1 | |
| 17 | Effect of electroacupuncture at Tianshu(ST 25) on colonic electromyography in Slow transit constipation rats | 2011 | 2 |
| 18 | 2011 | 107 | |
| 19 | 2006 | 45 | |
| 20 | The Toxic Effects of Bisphenol A on Human Embryo Liver L-02 Cells | 2005 | 1 |
About Bin Lü
Bin Lü is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Physiology, Endocrine and Autonomic Systems and Cardiology and Cardiovascular Medicine, having authored 160 papers that have together received 2.7k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (17 papers), Pituitary Gland Disorders and Treatments (12 papers), Liver Disease Diagnosis and Treatment (11 papers), Cardiovascular Health and Disease Prevention (10 papers), Botulinum Toxin and Related Neurological Disorders (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Growth Hormone and Insulin-like Growth Factors (9 papers) and Diabetic Foot Ulcer Assessment and Management (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (768 citations), Nephrology (230 citations), Hepatology (184 citations), Physiology (571 citations) and Endocrine and Autonomic Systems (115 citations). Bin Lü has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Renming Hu, Zhaoyun Zhang, Jie Wen, Yehong Yang, Shuo Zhang, Hangping Zheng, Linuo Zhou, Yiming Li, Xiaoming Zhu and Xuanchun Wang. Their work appears in journals such as Diabetes Research and Clinical Practice, Diabetology & Metabolic Syndrome, Infection and Drug Resistance, Diabetic Medicine and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.